ArticleJournal of orthopaedic surgery and research2026
LncRNA TUG1 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by regulating miR-138/SIRT1 axis.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to determine whether long non-coding RNA (lncRNA) taurine up-regulated gene 1 (TUG1) can promote the osteogenic differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs) by modulating the miR-138/silent information regulator 1 (SIRT1) axis and to explore the underlying mechanisms.
methodsTechniques including flow cytometry, cell staining analysis, quantitative real-time polymerase chain reaction (qRT-PCR), Western blot assay, and dual-luciferase reporter assay were utilized. Osteogenic induction was performed on hUC-MSCs that had undergone passage culture and surface marker characterization, and the level changes of TUG1 were detected. By respectively knocking down or overexpressing TUG1 and miR-138, the effects on osteogenic differentiation of hUC-MSCs were clarified, as well as the interaction between miR-138 and TUG1.Through the knockdown or overexpression of miR-138, the impact of miR-138 on the expression level of SIRT1 was determined. hUC-MSCs were categorized into three groups: the Vector + miR-NC group, the TUG1 + miR-NC group, and the TUG1 + miR-138 mimic group. The expression levels of SIRT1 and osteogenic marker genes were compared across these groups to elucidate the relationship among TUG1, miR-138, and SIRT1 during osteogenic differentiation.
resultsDuring the osteogenic differentiation of hUC-MSCs, the level of TUG1 increased progressively. The overexpression of TUG1 was capable of facilitating the expression of osteogenic marker genes, accompanied by an increase in the number of mineralized nodules. TUG1 and miR-138 exhibit a reciprocal inhibitory relationship. Moreover, miR-138 shows a negative correlation with both the expression of osteogenic marker genes and the formation of mineralized nodules. SIRT1 serves as a downstream target of miR-138, and its expression is subject to negative regulation by miR-138. Compared with the Vector + miR-NC group, the expression of SIRT1 and osteogenic marker genes was significantly increased in the TUG1 + miR-NC group, while overexpression of miR-138 could counteract the effect of TUG1.
conclusionsThe lncRNA TUG1 promotes the osteogenic differentiation of hUC-MSCs by modulating the miR-138/SIRT1 axis. This molecular mechanism may offer valuable insights for the prevention and treatment of osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.